Some Chinese researchers have reported that approximately 50% of ccRCC patients have VHL mutations (14), and our results show that VHL is approximately 51% in all RCCs and 78% in ccRCCs, which is similar to that in previous reports. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.